ArticleCancer discovery2022

Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML.

Jessica M Salmon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.